
0:00
12:44
For decades, magnesium sat in the supplement aisle as a mineral for muscle cramps, sleep, and general nutrition. Around 2010, that changed. A branded form called magnesium L-threonate launched on the back of a 2010 MIT rodent paper, and a new category was born — magnesium for the brain. Fifteen years later, that category has expanded to include other brand-targeted forms, premium price points, and confident claims about cognition, memory, and synaptic density. In this investigation, we review the science underneath those claims.
IN THIS INVESTIGATION
- What two papers from 1984 actually said about magnesium and the brain
- Why magnesium concentrates differently in brain fluid than in blood, and what that implies for supplementation
- The 2010 MIT paper that launched the brand-targeted magnesium category, and the question it didn't answer
- What you find when you trace the authorship of the rodent studies that "independently confirmed" the original
- The magnesium acetyl taurate line and what a 2026 head-to-head comparison reveals about form-specific brain delivery
- Every human trial on magnesium L-threonate, who funded each one, and the structural feature they all share
- The 2024 paper that directly measured magnesium inside living human brains for the first time in twenty-five years
- What the ordinary forms — citrate, chloride, oxide — have actually demonstrated in independent human trials
- Why a failed 2007 traumatic brain injury trial matters for everything that followed
- The single piece of evidence the brand-targeted magnesium story has never produced
- What to do if you take magnesium for cognitive reasons
Subscribe for more investigations.
Flere episoder fra "The Active Site"



Gå ikke glip af nogen episoder af “The Active Site” - abonnér på podcasten med gratisapp GetPodcast.








